LIVZON PHARMAC Net Income vs. Revenue
| LP6 Stock | EUR 3.40 0.18 5.59% |
For LIVZON PHARMAC profitability analysis, we use financial ratios and fundamental drivers that measure the ability of LIVZON PHARMAC to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well LIVZON PHARMAC GRP utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between LIVZON PHARMAC's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of LIVZON PHARMAC GRP over time as well as its relative position and ranking within its peers.
LIVZON |
LIVZON PHARMAC GRP Revenue vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining LIVZON PHARMAC's current stock value. Our valuation model uses many indicators to compare LIVZON PHARMAC value to that of its competitors to determine the firm's financial worth. LIVZON PHARMAC GRP is rated fourth overall in net income category among its peers. It is rated third overall in revenue category among its peers totaling about 17.81 of Revenue per Net Income. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LIVZON PHARMAC's earnings, one of the primary drivers of an investment's value.LIVZON Revenue vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
LIVZON PHARMAC |
| = | 684.16 M |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
LIVZON PHARMAC |
| = | 12.18 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
LIVZON Revenue vs Competition
LIVZON PHARMAC GRP is rated third overall in revenue category among its peers. Market size based on revenue of Drug Manufacturers-Specialty & Generic industry is now estimated at about 66.27 Billion. LIVZON PHARMAC retains roughly 12.18 Billion in revenue claiming about 18% of equities under Drug Manufacturers-Specialty & Generic industry.
LIVZON PHARMAC Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in LIVZON PHARMAC, profitability is also one of the essential criteria for including it into their portfolios because, without profit, LIVZON PHARMAC will eventually generate negative long term returns. The profitability progress is the general direction of LIVZON PHARMAC's change in net profit over the period of time. It can combine multiple indicators of LIVZON PHARMAC, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Livzon Pharmaceutical Group Inc. engages in the research, development, production, and distribution of pharmaceutical products in the Peoples Republic of China. Livzon Pharmaceutical Group Inc. was founded in 1985 and is based in Zhuhai, China. Livzon Pharmaceutical operates under Drug Manufacturers - Specialty Generic classification in Germany and traded on Frankfurt Stock Exchange. It employs 6963 people.
LIVZON Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on LIVZON PHARMAC. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of LIVZON PHARMAC position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the LIVZON PHARMAC's important profitability drivers and their relationship over time.
Use LIVZON PHARMAC in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LIVZON PHARMAC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LIVZON PHARMAC will appreciate offsetting losses from the drop in the long position's value.LIVZON PHARMAC Pair Trading
LIVZON PHARMAC GRP Pair Trading Analysis
The ability to find closely correlated positions to LIVZON PHARMAC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LIVZON PHARMAC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LIVZON PHARMAC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LIVZON PHARMAC GRP to buy it.
The correlation of LIVZON PHARMAC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LIVZON PHARMAC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LIVZON PHARMAC GRP moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LIVZON PHARMAC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your LIVZON PHARMAC position
In addition to having LIVZON PHARMAC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Power Assets Thematic Idea Now
Power Assets
Large capitalization equities showing high long-term performance indicators and above average return expectations based on Macroaxis rating system. The Power Assets theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Power Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in LIVZON Stock
To fully project LIVZON PHARMAC's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of LIVZON PHARMAC GRP at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include LIVZON PHARMAC's income statement, its balance sheet, and the statement of cash flows.